SS Innovations International (SSII) Cash & Current Investments (2016 - 2026)
SS Innovations International recorded quarterly Cash & Current Investments of $23.6 million in Q1 2026, up 158.21% quarter-over-quarter from $9.1 million in Q4 2025, and up 8.51% year-over-year from $21.8 million in Q1 2025.
SS Innovations International's Cash & Current Investments history runs 11 years deep, the most recent figure standing at $23.6 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 8.51% year-over-year to $23.6 million; the TTM figure through Mar 2026 stood at $23.6 million (up 8.51% YoY), while the FY2025 annual figure was $9.1 million, up 45.03% from the prior year.
- Cash & Current Investments came in at $23.6 million for Q1 2026 at SS Innovations International, up from $9.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $23.6 million in Q1 2026 to a low of $261089.0 in Q2 2022.
- A 5-year average of $7.3 million and a median of $6.3 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 2467.84% in 2023 and sank 50.2% in 2024, its largest moves.
- SS Innovations International's Cash & Current Investments stood at $274625.0 in 2022, then surged by 2467.84% to $7.1 million in 2023, then fell by 10.59% to $6.3 million in 2024, then jumped by 45.03% to $9.1 million in 2025, then jumped by 158.21% to $23.6 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $23.6 million, $9.1 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 23.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.61 Mn |
| Dec 31, 2025 | 9.14 Mn |
| Sep 30, 2025 | 11.71 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 21.76 Mn |
| Dec 31, 2024 | 6.31 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 813,453.00 |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 7.05 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 466,346.00 |
| Mar 31, 2023 | 448,543.00 |
| Dec 31, 2022 | 274,625.00 |
| Sep 30, 2022 | 514,143.00 |
| Jun 30, 2022 | 261,089.00 |
| Mar 31, 2022 | 346,869.00 |
| Dec 31, 2021 | 405,774.00 |
| Sep 30, 2021 | 205,195.00 |
| Jun 30, 2021 | 307,565.00 |
| Mar 31, 2021 | 316,813.00 |
| Dec 31, 2020 | 160,709.00 |
| Sep 30, 2020 | 685.00 |
| Jun 30, 2020 | 5,416.00 |
| Mar 31, 2020 | 10,120.00 |
| Dec 31, 2019 | 28,474.00 |
| Sep 30, 2019 | 29,967.00 |
| Jun 30, 2019 | 39,095.00 |
| Mar 31, 2019 | 61,530.00 |
| Dec 31, 2018 | 35,716.00 |
| Sep 30, 2018 | 100,182.00 |
| Jun 30, 2018 | 191,693.00 |
| Mar 31, 2018 | 314,672.00 |
| Dec 31, 2017 | 452,572.00 |
| Sep 30, 2017 | 520,855.00 |
| Jun 30, 2017 | 129,556.00 |
| Mar 31, 2017 | 255,476.00 |
| Dec 31, 2016 | 248,219.00 |
| Sep 30, 2016 | 288,726.00 |
| Jun 30, 2016 | 370,171.00 |